Human B-1 cells take the stage

Annals of the New York Academy of Sciences

Volumn 1285, Issue 1, 2013, Pages 97-114

  Rothstein, Thomas L ^a,b   Griffin, Daniel O ^a   Holodick, Nichol E ^a   Quach, Tam D ^a   Kaku, Hiroaki ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

Antibody; B cells; B 1; Lymphocytes

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE ANTIBODY; B LYMPHOCYTE RECEPTOR; CD11B ANTIGEN; CD20 ANTIGEN; CD27 ANTIGEN; CD5 ANTIGEN; CD70 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN 10; LEUKOSIALIN; MEMBRANE ANTIGEN; PHOSPHATIDYLCHOLINE; PHOSPHORYLCHOLINE;

ANTIBODY PRODUCTION; ANTIBODY STRUCTURE; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; B 1 CELL; B 2 CELL; B LYMPHOCYTE; BACTERIAL MEMBRANE; CARDIOVASCULAR DISEASE; CELL EXPANSION; CELL LINEAGE; CELL MANIPULATION; CELL MATURATION; CELL STIMULATION; CELLULAR IMMUNITY; CHRONIC LYMPHATIC LEUKEMIA; ERYTHROCYTE MEMBRANE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE STRUCTURE; MEMORY CELL; NONHUMAN; PLASMA CELL DYSCRASIA; SOMATIC HYPERMUTATION; SOMATIC MUTATION; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL; UMBILICAL CORD BLOOD;

EID: 84878182870     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12137     Document Type: Article

References (191)

1. Tony, H.P. & D.C. Parker 1985. Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of antiimmunoglobulin presented by small B lymphocytes. J. Exp. Med. 161: 223-241.
2. Emery, P., R. Fleischmann, A. Filipowicz-Sosnowska, et al. 2006. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthr. Rheum 54: 1390-1400.
3. Edwards, J.C., L. Szczepanski, J. Szechinski, et al. 2004. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl., J. Med. 350: 2572-2581.
4. Cohen, S.B., P. Emery, M.W. Greenwald, et al. 2006. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthr. Rheum 54: 2793-2806.
5. Lu, T.Y., K.P. Ng, G. Cambridge, et al. 2009. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients. Arthr. Rheum 61: 482-487.
6. Looney, R.J., J.H. Anolik, D. Campbell, et al. 2004. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthr. Rheum 50: 2580-2589.
7. Merrill, J.T., C.M. Neuwelt, D.J. Wallace, et al. 2010. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthr. Rheum 62: 222-233.
8. Coca, A. & I. Sanz 2009. B cell depletion in lupus and Sjogren's syndrome: an update. Curr. Opin. Rheumatol. 21: 483-488.
9. Steiner, L.A. & H.N. Eisen 1967. Sequential changes in the relative affinity of antibodies synthesized during the immune response. J. Exp. Med. 126: 1161-1183.
10. Martin, F., A.M. Oliver & J.F. Kearney 2001. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
11. Dunn-Walters, D.K., P.G. Isaacson & J. Spencer 1995. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J. Exp. Med. 182: 559-566.
12. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
13. Wang, C.Y., R.A. Good, P. Ammirati, et al. 1980. Identification of a p69, 71 complex expressed on human T cells sharing determinants with B-type chronic lymphatic leukemic cells. J. Exp. Med. 151: 1539-1544.
14. Lanier, L.L., N.L. Warner, J.A. Ledbetter & L.A. Herzenberg 1981. Expression of Lyt-1 antigen on certain murine B cell lymphomas. J. Exp. Med. 153: 998-1003.
15. Manohar, V., E. Brown, W.M. Leiserson & T.M. Chused 1982. Expression of Lyt-1 by a subset of B lymphocytes. J. Immunol. 129: 532-538.
16. Hardy, R.R., K. Hayakawa, J. Haaijman & L.A. Herzenberg 1982. B-cell subpopulations identifiable by two-color fluorescence analysis using a dual-laser FACS. Ann. N.Y. Acad. Sci. 399: 112-121.
17. Kantor, A.B., A.M. Stall, S. Adams & L.A. Herzenberg 1992. Differential development of progenitor activity for three B-cell lineages. Proc. Natl. Acad. Sci. USA 89: 3320-3324.
18. Ghosn, E.E., R. Yamamoto, S. Hamanaka, et al. 2012. Distinct B-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 109: 5394-5398.
19. Tornberg, U.C. & D. Holmberg 1995. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressures. Embo J. 14: 1680-1689.
20. Vink, A., G. Warnier, F. Brombacher & J.C. Renauld 1999. Interleukin 9-induced in vivo expansion of the B-1 lymphocyte population. J. Exp. Med. 189: 1413-1423.
21. Alugupalli, K.R., J.M. Leong, R.T. Woodland, et al. 2004. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 21: 379-390.
22. Haas, K.M., J.C. Poe, D.A. Steeber & T.F. Tedder 2005. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23: 7-18.
23. Hayakawa, K., R.R. Hardy, D.R. Parks & L.A. Herzenberg 1983. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157: 202-218.
24. Hayakawa, K., R.R. Hardy & L.A. Herzenberg 1986. Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur. J. Immunol. 16: 450-456.
25. Ishida, H., R. Hastings, J. Kearney & M. Howard 1992. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J. Exp. Med. 175: 1213-1220.
26. Kroese, F.G., W.A. Ammerlaan & A.B. Kantor 1993. Evidence that intestinal IgA plasma cells in mu, kappa transgenic mice are derived from B-1 (Ly-1 B) cells. Int. Immunol. 5: 1317-1327.
27. + B cells in viable motheaten and normal mice. Science 232: 1423-1425.
28. Holodick, N.E., J.R. Tumang & T.L. Rothstein 2010. B1 cells constitutively secrete IgM independently of IRF4. Eur. J. Immunol. 40: 3007-3016.
29. Choi, Y.S., J.A. Dieter, K. Rothaeusler, et al. B-1 cells in the bone marrow are a significant source of natural IgM. Eur. J. Immunol. 42: 120-129.
30. Kawahara, T., H. Ohdan, G. Zhao, et al. 2003. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J. Immunol. 171: 5406-5414.
31. Itakura, A., M. Szczepanik, R.A. Campos, et al. 2005. An hour after immunization peritoneal B-1 cells are activated to migrate to lymphoid organs where within 1 day they produce IgM antibodies that initiate elicitation of contact sensitivity. J. Immunol. 175: 7170-7178.
32. Ha, S.A., M. Tsuji, K. Suzuki, et al. 2006. Regulation of B1 cell migration by signals through Toll-like receptors. J. Exp. Med. 203: 2541-2550.
33. Yang, Y., J.W. Tung, E.E. Ghosn, et al. 2007. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc. Natl. Acad. Sci. USA 104: 4542-4546.
34. Wardemann, H., T. Boehm, N. Dear & R. Carsetti 2002. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J. Exp. Med. 195: 771-780.
35. Kretschmer, K., J. Stopkowicz, S. Scheffer, et al. 2004. Maintenance of peritoneal B-1a lymphocytes in the absence of the spleen. J. Immunol. 173: 197-204.
36. Yang, Y., E.E. Ghosn, L.E. Cole, et al. 2012. Antigen-specific memory in B-1a and its relationship to natural immunity. Proc. Natl. Acad. Sci. USA 109: 5388-5393.
37. Yang, Y., E.E. Ghosn, L.E. Cole, et al. 2012. Antigen-specific antibody responses in B-1a and their relationship to natural immunity. Proc. Natl. Acad. Sci. USA 109: 5382-5387.
38. Baccala, R., T.V. Quang, M. Gilbert, et al. 1989. Two murine natural polyreactive autoantibodies are encoded by nonmutated germ-line genes. Proc. Natl. Acad. Sci. USA 86: 4624-4628.
39. Hartman, A.B., C.P. Mallett, J. Srinivasappa, et al. 1989. Organ reactive autoantibodies from non-immunized adult BALB/c mice are polyreactive and express non-biased VH gene usage. Mol. Immunol. 26: 359-370.
40. Lalor, P.A. & G. Morahan 1990. The peritoneal Ly-1 (CD5) B cell repertoire is unique among murine B cell repertoires. Eur. J. Immunol. 20: 485-492.
41. + B cells. J. Immunol. 144: 4520-4525.
42. Ochsenbein, A.F., T. Fehr, C. Lutz, et al. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159.
43. Baumgarth, N., O.C. Herman, G.C. Jager, et al. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192: 271-280.
44. Boes, M., A.P. Prodeus, T. Schmidt, et al. 1998. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188: 2381-2386.
45. Briles, D.E., M. Nahm, K. Schroer, et al. 1981. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J. Exp. Med. 153: 694-705.
46. Mouquet, H., J.F. Scheid, M.J. Zoller, et al. 2010. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 467: 591-595.
47. Briles, D.E., C. Forman, S. Hudak & J.L. Claflin 1982. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae. J. Exp. Med. 156: 1177-1185.
48. Shaw, P.X., C.S. Goodyear, M.K. Chang, et al. 2003. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J. Immunol. 170: 6151-6157.
49. Hardy, R.R., C.E. Carmack, S.A. Shinton, et al. 1989. A single VH gene is utilized predominantly in anti-BrMRBC hybridomas derived from purified Ly-1 B cells. Definition of the VH11 family. J. Immunol. 142: 3643-3651.
50. + (CD5) B cells. Eur. J. Immunol. 19: 2115-2121.
51. Chen, Y., S. Khanna, C.S. Goodyear, et al. 2009. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol. 183: 1346-1359.
52. Boes, M., T. Schmidt, K. Linkemann, et al. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97: 1184-1189.
53. Tsimikas, S., E.S. Brilakis, R.J. Lennon, et al. 2007. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J. Lipid Res. 48: 425-433.
54. Soto, Y., H. Conde, R. Aroche, et al. 2009. Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease. Hum. Antibodies 18: 109-117.
55. Kyaw, T., C. Tay, S. Krishnamurthi, et al. 2011. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ. Res. 109: 830-840.
56. Gu, H., I. Forster & K. Rajewsky 1990. Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation. Embo J. 9: 2133-2140.
57. Forster, I., H. Gu & K. Rajewsky 1988. Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. Embo J. 7: 3693-3703.
58. Pennell, C.A., T.J. Mercolino, T.A. Grdina, et al. 1989. Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur. J. Immunol. 19: 1289-1295.
59. Benedict, C.L. & J.F. Kearney 1999. Increased junctional diversity in fetal B cells results in a loss of protective anti-phosphorylcholine antibodies in adult mice. Immunity 10: 607-617.
60. Desiderio, S.V., G.D. Yancopoulos, M. Paskind, et al. 1984. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature 311: 752-755.
61. Jacob, J., G. Kelsoe, K. Rajewsky & U. Weiss 1991. Intraclonal generation of antibody mutants in germinal centres. Nature 354: 389-392.
62. Hayakawa, K., R.R. Hardy & L.A. Herzenberg 1985. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J. Exp. Med. 161: 1554-1568.
63. Solvason, N., A. Lehuen & J.F. Kearney 1991. An embryonic source of Ly1 but not conventional B cells. Int. Immunol. 3: 543-550.
64. Kantor, A. 1991. A new nomenclature for B cells. Immunol. Today 12: 388.
65. Hayakawa, K., R.R. Hardy, A.M. Stall & L.A. Herzenberg 1986. Immunoglobulin-bearing B cells reconstitute and maintain the murine Ly-1 B cell lineage. Eur. J. Immunol. 16: 1313-1316.
66. + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17: 521-528.
67. Hardy, R.R. & K. Hayakawa 1991. A developmental switch in B lymphopoiesis. Proc. Natl. Acad. Sci. USA 88: 11550-11554.
68. Kantor, A.B. & L.A. Herzenberg 1993. Origin of murine B cell lineages. Annu. Rev. Immunol. 11: 501-538.
69. Yuan, J., C.K. Nguyen, X. Liu, et al. Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science 335: 1195-1200.
70. - B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int. Immunol. 3: 467-476.
71. + B cell precursor in B-1 cell differentiation. J. Exp. Med. 187: 1325-1334.
72. Arnold, L.W., C.A. Pennell, S.K. McCray & S.H. Clarke 1994. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J. Exp. Med. 179: 1585-1595.
73. + B cells both in vivo and in vitro. J. Immunol. 164: 4586-4593.
74. Fruman, D.A., A.B. Satterthwaite & O.N. Witte 2000. Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13: 1-3.
75. Kozlowski, M., I. Mlinaric-Rascan, G.S. Feng, et al. 1993. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 178: 2157-2163.
76. Shultz, L.D., P.A. Schweitzer, T.V. Rajan, et al. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73: 1445-1454.
77. Wortis, H.H. & R. Berland 2001. Cutting edge commentary: origins of B-1 cells. J. Immunol. 166: 2163-2166.
78. Montecino-Rodriguez, E., H. Leathers & K. Dorshkind 2006. Identification of a B-1 B cell-specified progenitor. Nat. Immunol. 7: 293-301.
79. Herzenberg, L.A. & J.W. Tung 2006. B cell lineages: documented at last! Nat. Immunol. 7: 225-226.
80. Yoshimoto, M., E. Montecino-Rodriguez, M.J. Ferkowicz, et al. 2011. Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potential. Proc. Natl. Acad. Sci. USA 108: 1468-1473.
81. Barber, C.L., E. Montecino-Rodriguez & K. Dorshkind 2011. Reduced production of B-1-specified common lymphoid progenitors results in diminished potential of adult marrow to generate B-1 cells. Proc. Natl. Acad. Sci. USA 108: 13700-13704.
82. Ghosn, E.E., P. Sadate-Ngatchou, Y. Yang & L.A. Herzenberg 2011. Distinct progenitors for B-1 and B-2 cells are present in adult mouse spleen. Proc. Natl. Acad. Sci. USA 108: 2879-2884.
83. - peritoneal B cells: a novel B cell subset that exhibits characteristics of B-1 cells. Immunol. Lett. 105: 90-96.
84. Zhong, X., J.R. Tumang, W. Gao, et al. 2007. PD-L2 expression extends beyond dendritic cells/macrophages to B1 cells enriched for V(H)11/V(H)12 and phosphatidylcholine binding. Eur. J. Immunol. 37: 2405-2410.
85. Tumang, J.R., N.E. Holodick, T.C. Vizconde, et al. 2011. A CD25-positive population of activated B1 cells expresses LIFR and responds to LIF. Front. Immunol. 2: 1-8.
86. Wang, H., D.-M. Shin, S. Abbasi, et al. 2012. Expression of plasma cell alloantigen 1 defines layered development of B-1a B-cell subsets with distinct innate-like functions. Proc. Natl. Acad. Sci. USA 109: 20077-20082.
87. Haury, M., A. Sundblad, A. Grandien, et al. 1997. The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur. J. Immunol. 27: 1557-1563.
88. Wasserman, R., Y.S. Li, S.A. Shinton, et al. 1998. A novel mechanism for B cell repertoire maturation based on response by B cell precursors to pre-B receptor assembly. J. Exp. Med. 187: 259-264.
89. Qian, Y., C. Santiago, M. Borrero, et al. 2001. Lupus-specific antiribonucleoprotein B cell tolerance in nonautoimmune mice is maintained by differentiation to B-1 and governed by B cell receptor signaling thresholds. J. Immunol. 166: 2412-2419.
90. Lam, K.P. & K. Rajewsky 1999. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 190: 471-477.
91. Hayakawa, K., M. Asano, S.A. Shinton, et al. 1999. Positive selection of natural autoreactive B cells. Science 285: 113-116.
92. Hayakawa, K., M. Asano, S.A. Shinton, et al. 2003. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med. 197: 87-99.
93. Duhren-von Minden, M., R. Ubelhart, D. Schneider, et al. 2012. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 489: 309-312.
94. + B cells. Eur. J. Immunol. 26: 2537-2540.
95. + B1 cells containing abundant N-region additions. Eur. J. Immunol. 39: 2383-2394.
96. Duber, S., M. Hafner, M. Krey, et al. 2009. Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood 114: 4960-4967.
97. Esplin, B.L., R.S. Welner, Q. Zhang, et al. 2009. A differentiation pathway for B1 cells in adult bone marrow. Proc. Natl. Acad. Sci. USA 106: 5773-5778.
98. Szabo, P., N. Relkin & M.E. Weksler 2008. Natural human antibodies to amyloid beta peptide. Autoimmun. Rev. 7: 415-420.
99. Britschgi, M., C.E. Olin, H.T. Johns, et al. 2009. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc. Natl. Acad. Sci. USA 106: 12145-12150.
100. Chapman, C.J., A. Murray, J.E. McElveen, et al. 2008. Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 63: 228-233.
101. Mizutamari, R.K., H. Wiegandt & G.A. Nores 1994. Characterization of anti-ganglioside antibodies present in normal human plasma. J. Neuroimmunol. 50: 215-220.
102. Sato, T., S. Ishikawa, K. Akadegawa, et al. 2004. Aberrant B1 cell migration into the thymus results in activation of CD4 T cells through its potent antigen-presenting activity in the development of murine lupus. Eur. J. Immunol. 34: 3346-3358.
103. Zhong, X., W. Gao, N. Degauque, et al. 2007. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells. Eur. J. Immunol. 37: 2400-2404.
104. Mohan, C., L. Morel, P. Yang & E. K. Wakeland 1998. Accumulation of splenic B1a cells with potent antigen-presenting capability in NZM2410 lupus-prone mice. Arthr. Rheum 41: 1652-1662.
105. Zhong, X., S. Lau, C. Bai, et al. 2009. A novel subpopulation of B1 B cells is enriched with autoreactivity in normal and lupus-prone mice. Arthr. Rheum 60: 3734-3743.
106. Murphy, T.P., D.L. Kolber & T.L. Rothstein 1990. Elevated expression of Pgp-1 (Ly-24) by murine peritoneal B lymphocytes. Eur. J. Immunol. 20: 1137-1142.
107. Tumang, J.R., W.D. Hastings, C. Bai & T.L. Rothstein 2004. Peritoneal and splenic B-1 cells are separable by phenotypic, functional, and transcriptomic characteristics. Eur. J. Immunol. 34: 2158-2167.
108. Karras, J.G., Z. Wang, L. Huo, et al. 1997. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes [see comments]. J. Exp. Med. 185: 1035-1042.
109. + B-1 cells have signaling properties similar to tolerant B cells. J. Biol. Chem. 277: 30707-30715.
110. Berland, R. & H.H. Wortis 2003. Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc. Natl. Acad. Sci. USA 100: 13459-13464.
111. Rothstein, T.L. & D.L. Kolber 1988. Anti-Ig antibody inhibits the phorbol ester-induced stimulation of peritoneal B cells. J. Immunol. 141: 4089-4093.
112. Morris, D.L. & T.L. Rothstein 1994. Decreased surface IgM receptor-mediated activation of phospholipase C gamma 2 in B-1 lymphocytes. Int. Immunol. 6: 1011-1016.
113. Morris, D.L. & T.L. Rothstein 1993. Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J. Exp. Med. 177: 857-861.
114. Holodick, N.E., J.R. Tumang & T.L. Rothstein 2009. Continual signaling is responsible for constitutive ERK phosphorylation in B-1a cells. Mol. Immunol. 46: 329-30360.
115. Hathcock, K.S., G. Laszlo, C. Pucillo, et al. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180: 631-640.
116. Wang, Y. & T.L. Rothstein 2012. Induction of Th17 cell differentiation by B-1 cells. Front. Immunol. 3: 281.
117. Wolf, S.D., B.N. Dittel, F. Hardardottir & C.A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med. 184: 2271-2278.
118. Fillatreau, S., C.H. Sweenie, M.J. McGeachy, et al. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
119. O'Garra, A., R. Chang, N. Go, et al. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur. J. Immunol. 22: 711-717.
120. + phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
121. Evans, J.G., K.A. Chavez-Rueda, A. Eddaoudi, et al. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178: 7868-7878.
122. Tian, J., D. Zekzer, L. Hanssen, et al. 2001. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167: 1081-1089.
123. Hahne, M., T. Renno, M. Schroeter, et al. 1996. Activated B cells express functional Fas ligand. Eur. J. Immunol. 26: 721-724.
124. Mariani, S.M. & P.H. Krammer 1998. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur. J. Immunol. 28: 1492-1498.
125. Strater, J., S.M. Mariani, H. Walczak, et al. 1999. CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L. Am. J. Pathol. 154: 193-201.
126. Lundy, S.K. & D.L. Boros 2002. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect. Immun. 70: 812-819.
127. Ring, S., A.H. Enk & K. Mahnke 2011. Regulatory T cells from IL-10-deficient mice fail to suppress contact hypersensitivity reactions due to lack of adenosine production. J. Invest. Dermatol. 131: 1494-1502.
128. Murakami, M., H. Yoshioka, T. Shirai, et al. 1995. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7: 877-882.
129. Rothstein, T.L. & D.L. Kolber 1988. Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. J. Immunol. 140: 2880-2885.
130. Miller, D.J. & C.E. Hayes 1991. Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur. J. Immunol. 21: 1123-1130.
131. Masuda, K., J. Wang & T. Watanabe 1997. Reduced susceptibility to Fas-mediated apoptosis in B-1 cells. Eur. J. Immunol. 27: 449-455.
132. Chumley, M.J., J.M. Dal Porto & J.C. Cambier 2002. The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen. J. Immunol. 169: 1735-1743.
133. Sen, G., H.J. Wu, G. Bikah, et al. 2002. Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations. Mol. Immunol. 39: 57-68.
134. + B (B-1) cells and immunity." In Handbook of B and T Lymphocytes. E. C. Snow, Eds.: 421-445 Academic Press, Inc. San Diego.
135. Bikah, G., J. Carey, J.R. Ciallella, et al. 1996. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274: 1906-1909.
136. Frances, R., J.R. Tumang & T.L. Rothstein 2007. Extreme skewing of annexin II and S100A6 expression identified by proteomic analysis of peritoneal B-1 cells. Int. Immunol. 19: 59-65.
137. Frances, R., J.R. Tumang, H. Kaku, et al. 2006. B-1 cells express transgelin 2: Unexpected lymphocyte expression of a smooth muscle protein identified by proteomic analysis of peritoneal B-1 cells. Mol. Immunol. 43: 2124-2129.
138. Fischer, G.M., L.A. Solt, W.D. Hastings, et al. 2001. Splenic and peritoneal B-1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells. Cell Immunol. 213: 62-71.
139. Tanguay, D.A., T.P. Colarusso, S. Pavlovic, et al. 1999. Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes. J. Exp. Med. 189: 1685-1690.
140. Tanguay, D.A., T.P. Colarusso, C. Doughty, et al. 2001. Cutting edge: differential signaling requirements for activation of assembled cyclin D3-cdk4 complexes in B-1 and B-2 lymphocyte subsets. J. Immunol. 166: 4273-4277.
141. Mataraza, J.M., J.R. Tumang, M.R. Gumina, et al. 2006. Disruption of cyclin D3 blocks proliferation of normal B-1a cells but loss of cyclin D3 is compensated by cyclin D2 in cyclin D3-deficient mice. J. Immunol. 177: 787-795.
142. Dasu, T., V. Sindhava, S.H. Clarke & S. Bondada 2009. CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes. Mol. Immunol. 46: 2655-2665.
143. -/- mice. J. Exp. Med. 194: 1141-1150.
144. Caligaris-Cappio, F., M. Gobbi, M. Bofill & G. Janossy 1982. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J. Exp. Med. 155: 623-628.
145. + B-cell subset. Science 236: 77-81.
146. + B cells. Science 236: 81-83.
147. Plater-Zyberk, C., R.N. Maini, K. Lam, et al. 1985. A rheumatoid arthritis B cell subset expresses a phenotype similar to that in chronic lymphocytic leukemia. Arthr. Rheum 28: 971-976.
148. Taniguchi, O., H. Miyajima, T. Hirano, et al. 1987. The Leu-1 B-cell subpopulation in patients with rheumatoid arthritis. J. Clin. Immunol. 7: 441-448.
149. + B cells from patients with rheumatoid arthritis. J. Exp. Med. 168: 1979-1992.
150. + B cells are polyreactive. J. Immunol. 140: 4180-4186.
151. Sims, G.P., R. Ettinger, Y. Shirota, et al. 2005. Identification and characterization of circulating human transitional B cells. Blood 105: 4390-4398.
152. + pre-naive B cell population. J. Immunol. 182: 4116-4126.
153. + B cells. Blood 73: 202-208.
154. + B cells predominate in peripheral tissues of rabbit. J. Immunol. 149: 3858-3864.
155. Wilson, S.M. & B.N. Wilkie 2007. B-1 and B-2 B-cells in the pig cannot be differentiated by expression of CD5. Vet. Immunol. Immunopathol. 115: 10-16.
156. Thiriot, A., A.M. Drapier, P. Vieira, et al. 2007. The Bw cells, a novel B cell population conserved in the whole genus Mus. J. Immunol. 179: 6568-6578.
157. Jego, G., R. Bataille & C. Pellat-Deceunynck 2001. Interleukin-6 is a growth factor for nonmalignant human plasmablasts. Blood 97: 1817-1822.
158. + B cells. J. Exp. Med. 205: 2033-2042.
159. + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188: 1679-1689.
160. +CD70. J. Exp. Med. 208: 67-80.
161. + B cells." J. Exp. Med. 208: 2566-2569.
162. Wells, S.M., A.B. Kantor & A.M. Stall 1994. CD43 (S7) expression identifies peripheral B cell subsets. J. Immunol. 153: 5503-5515.
163. Jacobi, A.M., J. Zhang, M. Mackay, et al. 2009. Phenotypic characterization of autoreactive B cells-checkpoints of B cell tolerance in patients with systemic lupus erythematosus. PLoS One 4: e5776.
164. + B cells and helper T cells in immunoglobulin production. Eur. J. Immunol. 27: 2073-2079.
165. Kruetzmann, S., M.M. Rosado, H. Weber, et al. 2003. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J. Exp. Med. 197: 939-945.
166. Shi, Y., T. Yamazaki, Y. Okubo, et al. 2005. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J. Immunol. 175: 3262-3267.
167. Griffin, D.O. & T.L. Rothstein 2012. Human B1 cell frequency: isolation and analysis of human B1 cells. Front. Immunol. 3: 122.
168. Carlsson, S.R. & M. Fukuda 1986. Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes. J. Biol. Chem. 261: 12779-12786.
169. van Lier, R.A., J. Borst, T. M. Vroom, et al. 1987. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 139: 1589-1596.
170. Descatoire, M., J.C. Weill, C.A. Reynaud & S. Weller 2011. A human equivalent of mouse B-1 cells? J. Exp. Med. 208: 2563-2564.
171. + B cells. J. Exp. Med. 208: 2565-2566; author reply 2566-2569.
172. - B cells generate antibodies to capsular polysaccharides of Streptococcus pneumoniae. J. Allergy Clin. Immunol. 130: 272-275.
173. Suchanek, O., R. Sadler, E.A. Bateman, et al. 2012. Immunophenotyping of putative human B1 B cells in healthy controls and common variable immunodeficiency (CVID) patients. Clin. Exp. Immunol. 170: 333-341.
174. Alugupalli, K.R., R.M. Gerstein, J. Chen, et al. 2003. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J. Immunol. 170: 3819-3827.
175. Vuyyuru, R., H. Liu, T. Manser & K.R. Alugupalli 2011. Characteristics of Borrelia hermsii infection in human hematopoietic stem cell-engrafted mice mirror those of human relapsing fever. Proc. Natl. Acad. Sci. USA 108: 20707-20712.
176. Istrin, G., E. Bosis & B. Solomon 2006. Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptide. J. Neurosci. Res. 84: 434-443.
177. Sapir, T. & Y. Shoenfeld 2005. Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy. Clin. Rev. Allergy Immunol. 29: 307-310.
178. Rodriguez-Zhurbenko, N., D. Martinez, R. Blanco, et al. 2013. Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic anti-tumor properties. Eur. J. Immunol. 43: 826-837.
179. Tiller, T., E. Meffre, S. Yurasov, et al. 2008. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J. Immunol. Methods 329: 112-124.
180. Mauri, C. & A. Bosma 2012. Immune regulatory function of B cells. Annu. Rev. Immunol.
181. Bouaziz, J.D., K. Yanaba & T.F. Tedder 2008. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev. 224: 201-214.
182. Blair, P.A., L.Y. Norena, F. Flores-Borja, et al. 2010. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32: 129-140.
183. Iwata, Y., T. Matsushita, M. Horikawa, et al. 2010. Characterization of a rare IL-10-competent B-cell subset in man that parallels mouse regulatory B10 cells. Blood 117: 530-541.
184. Bouaziz, J.D., S. Calbo, M. Maho-Vaillant, et al. 2010. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur. J. Immunol. 40: 2686-2691.
185. + human B1 cell subpopulation stimulates T cells and is expanded in lupus. J. Exp. Med. 208: 2591-2598.
186. Reynaud, C.A. & J.C. Weill 2012. Gene profiling of CD11b(+) and CD11b(-) B1 cell subsets reveals potential cell sorting artifacts. J. Exp. Med. 209: 433-434; author reply 434-436.
187. - B1 cell subsets reveals potential cell sorting artifacts." J. Exp. Med. 209: 434-436.
188. + T cells. J. Leukoc. Biol. 91: 525-536.
189. Cumano, A., C.J. Paige, N.N. Iscove & G. Brady 1992. Bipotential precursors of B cells and macrophages in murine fetal liver. Nature 356: 612-615.
190. Montecino-Rodriguez, E., H. Leathers & K. Dorshkind 2001. Bipotential B-macrophage progenitors are present in adult bone marrow. Nat. Immunol. 2: 83-88.
191. + B1 cells spontaneously secrete IL-10 and regulate T cell activity. Mol. Med. 18: 1003-1008.